In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 
Orange County Contact the County Orange County Seal

 

Health Care Agency
Public Health Services
Epidemiology & Assessment
(714) 834-8180
Fax: (714) 834-8196
Email: EPI@ochca.com

Health Referral Line
(800) 564-8448
(800) 801-7100 TDD
 

References & Resources
Epidemiology & Assessment

 

DISCLAIMER: Unless otherwise specified, Epidemiology & Assessment (CDCE) does not maintain nor is it responsible for the content of any of the outside sites linked to our Web pages. Inclusion of a website address in our list of "links" does not indicate endorsement.

Note: these sites contain pictures that may not be suitable for children and non-health care professionals.


Centers for Disease Control and Prevention

back to top

The Journal of the American Medical Association
NOTE: If you do not have a subscription to JAMA, please register as a guest to access the
following free content articles.

  • JAMA series (available at: http://jama.ama-assn.org/)

    • Anthrax as a Biological Weapon, 2002. Updated Recommendations for Management.  May 1, 2002 (Vol 287, No 17: 2236-2252), full text or pdf

    • Anthrax as a Biological Weapon. May 12, 1999 (Vol 281, No 18: 1735-1745), full text or pdf

    • Smallpox as a Biological Weapon. June 9, 1999 (Vol 281, No 22: 2127-2137), full text or pdf

    • Plague as a Biological Weapon. May 3, 2000 (Vol 283, No 17:2281-2289), full text or pdf

    • Botulinum toxin as a Biological Weapon. Feb. 28, 2001 (Vol 285, No. 8: 1059-1070), full text or pdf

    • Tularemia as a Biological Weapon. June 6, 2001 (Vol 285, No. 21:2763-2773), full text or pdf

    • Hemorrhagic Fever Viruses as Biological Weapons: Medical and Public Health Management. May 8, 2002 (Vol 287, No. 18:2391-2405), full text or pdf

  • Mayer TA, Bersoff- Matcha S, Murphy C. Clinical presentation of inhalational anthrax following bioterrorism exposure-report of 2 surviving patients. JAMA 2001;286:2549-2553
    http://jama.ama-assn.org/cgi/content/full/286/20/2549
     
  • Borio L, Frank D, Mani V. Death due to bioterrorism-related inhalational anthrax -report of 2 patients. JAMA 2001;286:2554-2559
    http://jama.ama-assn.org/cgi/content/full/286/20/2554
     
  • JAMA: August 6, 1997 (Vol. 278, No.5) issue on biological warfare and terrorism.  See http://jama.ama-assn.org/content/vol278/issue5/index.dtl for list of articles.  Includes Clinical Recognition and Management of Patients Exposed to Biological Warfare Agents. Abstract available at http://jama.ama-assn.org/cgi/content/abstract/278/5/399.  Authors from the United States Army Medical Research Institute of Infectious Diseases.

back to top

The New England Journal of Medicine

back to top

Other Web Sites

back to top